Abstract:This study aims to explore the effect of epigallocatechin gallate (EGCG) on blood lipids, liver lipids, and cholesterol synthesis in hyperlipidemic rats. SREBP-2 transgenic rats were used to investigate the transcriptional level of SREBP-2 regulated by SIRT-1/FOXO1 and the molecular mechanism of rate-limiting enzyme HMGCR that affects cholesterol synthesis. Rat models of hyperlipidemia were established and administered EGCG. Cholesterol synthesis was observed. Enzyme linked immunosorbent assay was used to determine serum triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), free fatty acid (FFA), superoxide dismutase (SOD), malondialdehyde (MDA), and T-AOC contents. Hematoxylin-eosin staining and oil red O staining were utilized to observe the histological changes in the liver. Biochemical method was applied to measure serum ALT and AST changes. Western blot assay and qRT-PCR were employed to detect the changes in SIRT1/FOXO1 pathway-related proteins, cholesterol synthesis-related genes, and SREBP-2. EGCG 50 mg/kg could obviously decrease the liver weight and liver coefficient, reduce serum TG, TC, LDL-C, and FFA levels (P < 0.05), and increase serum HDL-C levels in hyperlipidemic rats. EGCG could diminish hyperlipidemia-induced liver injury and reduce serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. Oil red O staining results demonstrated that the number of red lipid droplets in hepatocytes reduced to varying degrees, especially high-dose EGCG. EGCG remarkably diminished MDA content in the liver with hypercholesterolemia and increased T-AOC and SOD activity. In the model group, SIRT1 expression increased, and FOXO1 expression decreased. EGCG activated SIRT1 and increased FOXO1 expression, whose expression trend was consistent with the fenofibrate group. HMGCR, FDPS, SS, and ABCA1 expression increased, and ACAT2 expression noticeably reduced in SREBP-2+/+ transgenic rats. EGCG could reverse the expression trend of each gene. Simultaneously, EGCG increased FOXO1 expression, and decrease SREBP-2 expression; however, no significant changes in these expression were found in SREBP-2−/− rats. EGCG can alleviate liver injury and oxidative stress in hyperlipidemic rats. EGCG can activate SIRT1, activate FOXO1 protein, regulate SREBP-2 protein, and inhibit hepatic cholesterol synthesis.

Cholesterol-lowering Activity of 10-Gingerol in HepG2 Cells is Associated with Enhancing LDL Cholesterol Uptake, Cholesterol Efflux and Bile Acid Excretion

6-Gingerol Regulates Hepatic Cholesterol Metabolism by Up-regulation of LDLR and Cholesterol Efflux-Related Genes in HepG2 Cells

Plasma Cholesterol-Lowering Activity of Gingerol- and Shogaol-Enriched Extract is Mediated by Increasing Sterol Excretion

Pungent Ginger Components Modulates Human Cytochrome P450 Enzymes in Vitro

10-Gingerol reduces cytoplasmic lipid droplets and induces lipolysis in 3T3-L1 adipocytes

Isolation of Gingerols and Its Preventive Effect on Insulin Resistance of HepG2 Cells

6-Gingerol Inhibits De Novo Lipogenesis by Targeting Stearoyl-CoA Desaturase to Alleviate Fructose-Induced Hepatic Steatosis

6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway

Inhibition of Human Ether-À-go-go-related Gene K+ Currents Expressed in HEK293 Cells by Three Gingerol Components from Ginger.

6‐Dihydroparadol, a Ginger Constituent, Enhances Cholesterol Efflux from THP‐1‐Derived Macrophages

Hypocholesterolemic activity of grape seed proanthocyanidin is mediated by enhancement of bile acid excretion and up-regulation of CYP7A1.

10-Gingerol Increases Antioxidant Enzymes and Attenuates Lipopolysaccharide-Induced Inflammation by Modulating Adipokines in 3T3-L1 Adipocytes

Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells

6-Gingerol Normalizes the Expression of Biomarkers Related to Hypertension Via PPARδ in HUVECs, HEK293, and Differentiated 3T3-L1 Cells.

Ginger Attenuates Trimethylamine-N-oxide (Tmao)-Exacerbated Disturbance in Cholesterol Metabolism and Vascular Inflammation

Separation and Preparation of 6-Gingerol from Molecular Distillation Residue of Yunnan Ginger Rhizomes by High-Speed Counter-Current Chromatography and the Antioxidant Activity of Ginger Oils in Vitro

Antioxidant Activities of Ginger Extract and Its Constituents Toward Lipids.

The Interaction Between Bovine Serum Albumin and [6]-,[8]- and [10]-Gingerol: an Effective Strategy to Improve the Solubility and Stability of Gingerol.

Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1/FOXO1 signaling pathway

Variations in the contents of gingerols and chromatographic fingerprints of ginger root extracts prepared by different preparation methods.

A mix of ginger phenols exhibits anti‑adipogenic and lipolytic effects in mature adipocytes derived from 3T3‑L1 cells